-
INCORPORATING REAL OPTION VALUE IN THE ECONOMIC EVALUATION OF OSIMERTINIB FOR ADVANCED EGFR-MUTATED NON-SMALL CELL LUNG CANCER
Feb 25, 2026, 14:41 PM -
AFFORDABILITY OF PEDIATRIC DRUGS THROUGH CHINA’S NATIONAL DRUG PRICE NEGOTIATION: 2017-2024
Feb 25, 2026, 14:41 PM -
METHODOLOGICAL COMPARISON OF CATEGORIZED VERSUS CONTINUOUS DECLINE IN KIDNEY FUNCTION: INSIGHTS FROM THE CKD CARE MODEL
Feb 25, 2026, 14:41 PM -
UNDERSTANDING CEA CHARACTERISTICS ASSOCIATED WITH COST-SAVING FINDINGS
Feb 25, 2026, 14:41 PM -
REAL-WORLD CHARACTERISTICS AND HEALTHCARE RESOURCE USE IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH BIMEKIZUMAB IN SWEDEN: THE BIMENORDIX STUDY
Feb 25, 2026, 14:41 PM -
DEVELOPMENT AND VALIDATION OF AN ALGORITHM TO IDENTIFY ASPIRIN USE FROM ELECTRONIC MEDICAL RECORDS AND CLAIMS DATA
Feb 25, 2026, 14:41 PM -
ADHERENCE TO MULTI-TARGET STOOL DNA TESTING FOR COLORECTAL CANCER SCREENING IN A NORTHEASTERN U.S. CORRECTIONAL FACILITY
Feb 25, 2026, 14:41 PM -
EVALUATING THE IMPACT OF THE INFLATION REDUCTION ACT OUT-OF-POCKET CAPS ON PATIENT ASSISTANCE FUNDS EFFICIENCY AND COVERAGE EXPANSION
Feb 25, 2026, 14:41 PM -
LEVERAGING GENERATIVE AI AND MACHINE LEARNING FOR ROBUST REAL-WORLD COHORT DEFINITION AND PATIENT JOURNEY INSIGHTS IN HIV RESEARCH
Feb 25, 2026, 14:41 PM -
LEVERAGING THE 2022 INFECTION PREVENTION AND CONTROL RESPONSE STRATEGY TO CONTROL THE 2025 SUDAN VIRUS DISEASE OUTBREAK IN EASTERN UGANDA
Feb 25, 2026, 14:41 PM -
APTITUDE TOWARDS PATIENT-CENTERED CARE AMONG PHYSICIANS MANAGING RARE DISEASES IN THE UNITED STATES: A CROSS-SECTIONAL SURVEY
Feb 25, 2026, 14:41 PM -
COST-EFFECTIVENESS OF LAZERTINIB-AMIVANTAMAB COMPARED TO OSIMERTINIB FOR NON-SMALL CELL LUNG CANCER: A 5-YEAR PARTITIONED SURVIVAL MODEL
Feb 25, 2026, 14:41 PM -
A MARKOV MODEL-BASED COST-EFFECTIVENESS ANALYSIS OF ACUPUNCTURE FOR NON-SPECIFIC LOW BACK PAIN IN HONG KONG
Feb 25, 2026, 14:41 PM -
ANALYSIS OF GENE THERAPIES AUTHORIZED BY HEALTH CANADA, AND COMPARISON WITH THE U.S. FOOD AND DRUG ADMINISTRATION, AND THE EUROPEAN MEDICINES AGENCY
Feb 25, 2026, 14:41 PM -
REAL-WORLD SURVIVAL AND PREDICTORS OF MORTALITY IN HEMATOLOGIC MALIGNANCIES DURING AN ERA OF THERAPEUTIC ADVANCEMENT AND HEALTHCARE DISRUPTION: A POPULATION-BASED SEER STUDY
Feb 25, 2026, 14:41 PM -
ASSOCIATION BETWEEN PINEAL NEOPLASM AND ALZHEIMER’S DISEASE PROGRESSION IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT: A POPULATION-BASED COHORT STUDY
Feb 25, 2026, 14:41 PM -
IDENTIFYING TENOSYNOVIAL GIANT CELL TUMOR (TGCT) IN SECONDARY DATA: METHODOLOGICAL CHALLENGES, EMERGING OPPORTUNITIES, AND FUTURE DIRECTIONS
Feb 25, 2026, 14:41 PM -
DRIVERS OF MOBILE PATIENT PORTAL APP USE: INSIGHTS FOR IMPLEMENTATION AND VALUE-BASED DECISION-MAKING
Feb 25, 2026, 14:41 PM -
ECONOMIC IMPACT OF INTRODUCING PCV20 IN COLOMBIAN PEDIATRIC POPULATION: A COST UTILITY ANALYSIS
Feb 25, 2026, 14:41 PM -
REAL-WORLD DEL(17P), TP53, AND IGHV BASELINE TESTING PATTERNS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITHIN A LARGE NETWORK OF US COMMUNITY ONCOLOGY PRACTICES
Feb 25, 2026, 14:41 PM
